#HCSM TweetChat Recap 8/16/09: T5 Social Media Tools For Pharma

Here is the summary for Topic 5 (of 5) from the Health Care and Social Media chat on August 16th, 2009 on Twitter.

53 people joined the chat with 636 tweets about #HCSM (134 were Re-tweets)

@tstitt moderated this night’s chat and provided this pre-briefing.

Anything retweeted 2x or more gets a bold and italics treatment- Minimal editing done for clarity. The info for the whole chat is split into three posts by topic

Here are all the topics for the night. The other three topics are highlighted in the linked posts.

T1 From a provider perspective, which social media Tools, Messages and Services are important now, next year & why?

T2 From a patient perspective, which Social Media Tools, Messages and Services are important now, next year & why?

T3 From a physician perspective, which social media Tools, Messages and Services are important now, next year & why?

T4 From a payor perspective, which which Social Media Tools, Messages and Services are important now, next year & why?

T5 From a pharma perspective, which which Social Media Tools, Messages and Services are important now, next year & why?

Here are the best tweets (IMHO) for TOPIC 5 – From a pharma perspective, which social media Tools, Messages and Services are important now, next year & why?

cyberslate @stephaniethum @ahier: T5: reduce medication errors ‘Pillbox; http://bit.ly/I4WZd

healthblawg see summary of rountdable on the legal/regulatory piece of this I facilitated last month http://bit.ly/jJz1M

tstitt When you think “pharma and social media”, what company or product, if any, comes to mind first?

DaphneLeigh @tstitt Novo Nordisk

philbaumann A good follow in Pharma is @pfizer_news – personable, interactive, good content sharing.

ahier Txt messages, etc. to remind take meds – renew Rx via social media

nanarcr @ahier Not sure txt messages to take meds, etc., w/work without requiring a response

stephaniethum @nanarcr @ahier Cincinnati Children’s just did a study on texting medication adherence reminders.

stephaniethum @ctsinclair @ahier @cyberslate @nanarcr Article re: texting medication adherence at Cincinnati Children’s http://bit.ly/pMvJn

qeanmedical Retweets of a pharma tweet with an added off-label use comment, ugh.

ctsinclair RT @qeanmedical: T5 Retweets of a pharma tweet with an added off-label use comment, ugh. “Pharama exec nightmare or dream?”

philbaumann @ctsinclair Good point, but patients with little voice aren’t usually egged on by cunning lobbyists who know media manipulation.

hillarts @philbaumann I think SM is one of the best ways to clear away media manipulation

philbaumann @hillarts Totally agree! Given our times, it’s one of its most important features. Not w/o its problems, but helpful nonetheless

ctsinclair @philbaumann But those may not be quick to correct the mis-information that leads to increased med use for off-label

gravityten pharma has a negative persona. They(collectively) can & should use socmed to bring them back to a positive brand perception

mkmackey More communication with clinical trials and seeking patients is important for pharma

tstitt E.g., the @racewithinsulin graphics & initial rules of engagement could have been better. But the campaign opened doors & minds.

blausengroup The more medical education a chronic disease patient can get the better they will be able to participate in managing their care

MeredithGould My sense is that pharma always plays the regulatory card to justify lag in social media adoption.

RickenFlow pharma companies will soon move from tv commericals to social media but probably wont engage folks

arthurwlane medication adherence and generic switching programs

nanarcr @JOSullivan @danielg280 Chronic condition monitoring long distance by email w/specialist works great 4 me. Good model to follow

MeredithGould @mageier Right. I’m thinking that we might not see what we think we should see relative to social class variables.

philbaumann Pharma’s got big challenges. Poor blokes. A lot seem to have started mainlining Twitter tho. That’s good, right?

healthblawg FDA has been mostly silent on its view of SM which keeps most pharma from doing anything

AccessCR Until lawyers start tweeting and engageing, they probably won’t let their clients, eg pharma….

danielg280 Yes, lawyers are starting to see the value of SoMe. many states have restrictions about attorney advertising which complicates it tho

arthurwlane also depends on how we look at pharma – as a PBMs or as drug manufactures

—————–

Join #hcsm on Tweetchat.com Sunday nights.

Tagged as: Chronic, Clinical trial, Health Care, Medicine, novo nordisk, Pfizer, pharma, Text messaging, Twitter